Methylene Blue for the Treatment of COVID-۱۹ in Pediatrics

Despite vaccination against SARS-CoV-۲, the COVID-۱۹ pandemic continues to expand worldwide. Early reports suggested that only a minor proportion of pediatric population is affected by COVID-۱۹ in comparison to adult population. Three percent of pediatric population needed admission to intensive care units, and only a small number of deaths have been reported. Available literature suggests that infants (children under ۱ year) seem to be more vulnerable to COVID-۱۹ virus infection with a higher severity of illness compared with other pediatric ages. Requirement for neonatal mechanical ventilation is ۲۰%–۲۲.۴% (vs. ۴% in children) (۱).

کلیدواژه ها:

COVID-۱۹ ، Treatment ، Methylene blue ، Pediatrics